Is there an antiandrogen withdrawal syndrome with enzalutamide?-Reference-Cited by-同舟云学术

Is there an antiandrogen withdrawal syndrome with enzalutamide?

Published:2014-10-24 Issue:3 Volume:115 Page:373-380
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Rodriguez-Vida Alejo¹,Bianchini Diletta²,Van Hemelrijck Mieke³,Hughes Simon¹,Malik Zafar⁴,Powles Thomas⁵,Bahl Amit⁶,Rudman Sarah¹,Payne Heather⁷,de Bono Johann²,Chowdhury Simon¹

Affiliation:

1. Guy's and St Thomas' NHS Foundation Trust; Great Maze Pond; London UK

2. Royal Marsden NHS Foundation Trust and Institute of Cancer Research; Sutton UK

3. King's College London; Division of Cancer Studies; Cancer Epidemiology Group; London UK

4. Clatterbridge Cancer Centre NHS Foundation Trust; Bebington UK

5. St. Bartholomew's Hospital NHS Foundation Trust; London UK

6. University Hospitals Bristol NHS Foundation Trust; Bristol UK

7. University College Hospital; London UK

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12826/fullpdf

Reference27 articles.

1. Prostate cancer incidence and mortality trends in 37 European countries: an overview;Bray;Eur J Cancer,2010

2. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma;Crawford;N Engl J Med,1989

3. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer;Eisenberger;N Engl J Med,1998

4. Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426);Sartor;Cancer,2008

5. Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583);Small;J Clin Oncol,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiandrogen Withdrawal Syndrome After Discontinuation of Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: A Report of Two Clinical Cases and a Literature Review;Cureus;2024-06-30

2. Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study;Molecular Cancer;2023-11-04

3. Spontaneous Remission of Metastatic Castration-Resistant Prostate Cancer: Coley’s Toxin Revisited?;Cureus;2022-12-14

4. Second generation androgen receptor antagonists and challenges in prostate cancer treatment;Cell Death & Disease;2022-07-21

5. Hormone Treatment of Prostate Cancer:;Urologic Clinics of North America;2022-05